Overnight, Invo Bioscience's stock price surged by 375% at one point, ultimately closing up 140% with a price of $1.82.
On the news front, as a medical device company focusing on the Assisted Reproductive Technology (ART) market, Invo achieved a revenue of $1.382 million in the fourth quarter of 2023, up 396.15% year-on-year from $0.27814 million. The earnings per share were -$0.64, compared to the previous -$4.60.
However, it is worth noting that the short interest data for the stock skyrocketed overnight: the number of shares being shorted suddenly surged from a few thousand to nearly 7 million shares, with the volume of short sales soaring to tens of millions.
<img src="https://pub.pbkrs.com/cms/2024/0/k7xV4rNo2mLMZZJAhV1xpXkzE3JvZUpQ.jpg?x-oss-process=style/lg" alt="" original-src="https://pub.pbkrs.com/cms/2024/0/k7xV4rNo2mLMZZJAhV1xpXkzE3JvZUpQ.jpg"/><img src="https://pub.pbkrs.com/cms/2024/0/JD4QdxvrSMnfViNzmYuzXrBxMAnaQKpw.jpg?x-oss-process=style/lg" alt="" original-src="https://pub.pbkrs.com/cms/2024/0/JD4QdxvrSMnfViNzmYuzXrBxMAnaQKpw.jpg"/>

NAYA

Why did Invo Bioscience soar? Its fourth-quarter revenue increased by 396.15% year-on-year! As for short selling data, the number of shares shorted overnight skyrocketed from just a few thousand or hundred shares to nearly 7 million shares, with the volume of short selling transactions surging to tens of millions

Overnight surged by 140%, short interest also surged! What happened to INVO?